Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -12.04%2.53B | 1.35%12.14B | 10.10%9.45B | 12.26%6.08B | 20.03%2.88B | 15.34%11.98B | 10.25%8.58B | 8.57%5.42B | 2.96%2.4B | 24.95%10.39B |
| Operating income | 1.35%12.14B | 12.26%6.08B | 15.34%11.98B | 8.57%5.42B | 24.95%10.39B | |||||
| Cost of sales | ---- | -1.11%-11.6B | ---- | -11.98%-5.8B | ---- | -16.84%-11.47B | ---- | -10.13%-5.18B | ---- | -26.61%-9.82B |
| Operating expenses | -1.11%-11.6B | -11.98%-5.8B | -16.84%-11.47B | -10.13%-5.18B | -26.61%-9.82B | |||||
| Gross profit | 6.69%543.06M | 18.31%285.09M | -10.54%509.01M | -16.80%240.97M | 1.90%568.99M | |||||
| Selling expenses | ---- | 9.68%-32.61M | ---- | 2.08%-17.93M | ---- | 10.84%-36.11M | ---- | 5.88%-18.31M | ---- | -68.62%-40.5M |
| Administrative expenses | ---- | 17.03%-196.27M | ---- | 12.87%-94.51M | ---- | -15.75%-236.54M | ---- | 2.37%-108.48M | ---- | 1.02%-204.35M |
| Impairment and provision | ---- | -815.80%-64.75M | ---- | ---- | ---- | ---7.07M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -815.80%-64.75M | ---- | ---- | ---- | ---7.07M | ---- | ---- | ---- | ---- |
| Special items of operating profit | ---- | -1,001.23%-61.8M | ---- | -424.03%-52.97M | ---- | 114.93%6.86M | ---- | 182.51%16.35M | ---- | 9.72%-45.92M |
| Operating profit | -51.86%26.06M | -20.54%187.64M | -10.52%169.81M | -8.31%119.68M | 5.64%54.14M | -15.12%236.15M | -11.22%189.77M | -6.26%130.53M | -5.48%51.25M | 0.43%278.22M |
| Financing cost | ---- | 11.86%-27.06M | ---- | 3.66%-14.81M | ---- | -16.64%-30.7M | ---- | -53.93%-15.37M | ---- | -37.14%-26.32M |
| Share of profits of associates | ---- | -91.71%2.05M | ---- | 180.52%14.56M | ---- | 119.43%24.68M | ---- | 44.33%-18.08M | ---- | -125.13%-127.05M |
| Share of profit from joint venture company | ---- | -23.26%99K | ---- | -94.44%1K | ---- | 358.00%129K | ---- | --18K | ---- | ---50K |
| Special items of earning before tax | ---- | 100.07%9K | ---- | ---- | ---- | -165.93%-13.38M | ---- | -247.66%-2.34M | ---- | 1,111.46%20.29M |
| Earning before tax | -24.97%162.73M | 26.03%119.43M | 49.48%216.88M | -3.67%94.77M | -28.56%145.09M | |||||
| Tax | ---- | -6.46%-48.82M | ---- | -22.97%-29.39M | ---- | 12.34%-45.85M | ---- | 10.29%-23.9M | ---- | -4.53%-52.31M |
| After-tax profit from continuing operations | -33.39%113.91M | 27.06%90.04M | 84.34%171.02M | -1.21%70.87M | -39.38%92.78M | |||||
| Earning after tax | -33.39%113.91M | 27.06%90.04M | 84.34%171.02M | -1.21%70.87M | -39.38%92.78M | |||||
| Minority profit | ---- | -92.42%2.3M | ---- | 5.28%13.84M | ---- | 12.72%30.27M | ---- | 4.27%13.14M | ---- | 54.66%26.85M |
| Profit attributable to shareholders | -124.76%-8.61M | -20.70%111.62M | -6.03%108.84M | 32.01%76.21M | 260.32%34.77M | 113.51%140.75M | 18.04%115.82M | -2.38%57.73M | -41.06%9.65M | -51.41%65.92M |
| Dividend | ---- | -52.00%10.89M | ---- | 150.00%22.69M | ---- | 25.00%22.69M | ---- | 0.00%9.08M | ---- | 0.00%18.15M |
| Basic earnings per share | -20.70%0.123 | 32.08%0.084 | 113.64%0.1551 | -2.15%0.0636 | -51.28%0.0726 | |||||
| Diluted earnings per share | 32.08%0.084 | -2.15%0.0636 | -51.28%0.0726 | |||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | -- | -- | KPMG | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.